• Aim & Scope

Aims and Scope

The Journal of Oncology Research & Clinical Treatment seeks to:

Encourage innovation and collaboration between basic scientists and clinical researchers in oncology.

Present cutting-edge research related to the prevention, diagnosis, treatment, and palliative care of cancer.

Foster global dissemination of studies addressing region-specific cancer burdens and treatment outcomes.

Provide a forum for critical discussions on personalized medicine, precision oncology, and clinical trial design.

The journal covers a wide range of topics, including but not limited to: Molecular and Cellular Oncology

Translational and Clinical Cancer Research

Chemotherapy and Radiotherapy Approaches

Immuno-oncology and Targeted Therapies

Surgical Oncology and Minimally Invasive Procedures

Biomarkers, Diagnostics, and Imaging

Hematologic Malignancies and Solid Tumors

Pediatric, Geriatric, and Rare Cancers

Cancer Epidemiology and Public Health

Quality of Life, Palliative Care, and Survivorship

🔑 Keywords

Oncology

Cancer Research

Clinical Oncology

Chemotherapy

Radiotherapy

Immunotherapy

Targeted Therapy

Cancer Diagnosis

Tumor Biology

Cancer Treatment

Precision Oncology

Surgical Oncology

Translational Research

Biomarkers

Cancer Epidemiology

Palliative Care

Cancer Survivorship

Oncogenomic

Hematologic Malignancies

Solid Tumors

• Author Guidelines

Instruction for Author Guidelines:

The submitted manuscripts should have minimum basic standards to be able to read and interpret the content by the Editorial team. The submissions which do not meet these criteria will be sent back to the authors.

Article Types & Format

Original/Research articles These are the articles which deal with unpublished data providing a detailed explanation of the Methods, Methodology and the results of an investigation supported by evidence. These articles, in general, can be divided into sections:

Introduction:

Identifies the aim of the research

Methods:

Describes the methods applied, study design and the all the details regarding the selection and of the participants of the study

Results:

Provides information regarding the results of the research

Conclusions:

Addressing relevant implications for clinical practice or health policy

Review

Deals with reporting of the literature review of already published data, providing a detailed and in-depth discussion of significant research topics and their development over time.

Case Reports

Articles describing the symptoms, diagnosis, and treatment of clinical cases—usually novel cases. These may also include a literature review of reported cases.

Editorial

Short articles written by the Editors or editorial staff of the journal.

Commentaries

Discuss various aspects of a focused research topic, offering critiques, solutions, or enhancements.

Corrigendum

Rectifications or adjustments made in an article due to author errors.

Expert Opinion

Articles written by experts to promote research or support knowledge advancement in specific areas.

Letter to Editor

Articles addressed to the Editor-in-Chief that comment, agree, or disagree with content in published articles. They can also correct or critique perceived errors.

Perspective

Expresses the author's individual viewpoint on a topic of interest. Basic manuscript structure includes: Cover Letter, Title page, Abstract and keywords, Main Content, Acknowledgments, References, Tables, and Figure legends.

Cover Letter

Should state article type, confirm exclusivity, summarize main points, and optionally name five referees with contact details.

Title Page

Max 15 words; should describe the work clearly. Use Times New Roman Bold, Title Case, and indicate corresponding author.

Abstract

Briefly states objectives, work done, significance, and findings. Should not exceed 300 words and must not contain citations.

Keywords

Include 7–10 key terms relevant to the study.

Abbreviations

Define all abbreviations at first use. If many, include a list under keywords.

Manuscript Text

No fixed structure; authors may divide as per study type. Cite references in superscript, number tables/figures in citation order, and place tables at the end with figures as separate files.

Conflicts of Interest

Declare any author conflicts to maintain transparency post-publication.

Acknowledgments

Mention contributors who don’t qualify for authorship. Include funding, assistance, and prior conference presentations. Obtain consent before naming individuals.

References

Follow Vancouver style. Include at least one online link (preferably PubMed). Format: Author(s). Title. Journal Abbr. Year; Volume : Pages.

Tables

•             Place after references

•             Use Word table tools, not figures

•             Number in order of citation

•             Do not duplicate data in the text

•             References within tables must be listed properly

Figure Legends

•             Include a manuscript end

•             Define symbols/parts clearly

•             Follow citation order

•             Get permission for reused figures

•             Figures must be .jpg/.tiff and high resolution

•             Do not submit figures as Word, PPT, or PDF

•             Mask identifiable clinical photos or provide consent

Article Processing Charges

Authors are required to pay 1019 USD as a processing fee. Publication of an article in the Journal of Oncology Research & Clinical Treatment is not contingent upon the author's ability to pay the charges. Neither is acceptance to pay the processing fee a guarantee that the paper will be accepted for publication. Authors may still request (in advance) that the editorial office waive some of the processing fee under special circumstances.

Withdraw Policy: 

If, due to certain circumstances, the author wishes to withdraw the article after submission, a withdrawal fee will be applicable.

Copyright

Copyright protects article content and findings. Academixs defends author work and responds seriously to claims of plagiarism, ethics breaches, or fraud. Contact us if you become aware of any such issues.

• Editorial Board

Professor

Alaa Kandil

Department of Clinical Oncology & Nuclear Medicine

Alexandria School of Medicine

Egypt

Professor

Andrew Hague

CellSonic Limited and the founder of Sapiens Shield

Honorary Fellow of the International Academy of Medical Sciences

United Kingdom

Professor,

Adrian P. Hunis MD

School of Medicine, Universidad de Buenos Aires, Argentina (UBA)

Emeritus Member of ASCO, Emeritus Member of ESMO, Honorary Member of AMA

Argentina

• PPT

• Videos

• Indexing